Matrix metalloproteinases and their inhibitors in malignant and autoreactive pericardial effusion

American Journal of Cardiology

Volumn 95, Issue 9, 2005, Pages 1065-1069

  Lamparter, Steffen ^a   Schoppet, Michael ^b   Christ, Michael ^b   Pankuweit, Sabine ^b   Maisch, Bernhard ^b  

^a Diakonie Krankenhaus Wehrda   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOLOGY; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; MALE; PATIENT; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SAMPLE; ZYMOGRAPHY;

EID: 17444401377     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.12.059     Document Type: Article

References (30)

1. J.F.J. Woessner The family of matrix metalloproteinases Ann NY Acad Sci 732 1994 11 21
2. P.W. Armstrong, G.W. Moe, R.J. Howard, E.A. Grima, T.F. Cruz Structural remodeling in heart failure: gelatinase induction Can J Cardiol 10 1994 214 220
3. F.G. Spinale, M.L. Coker, C.V. Thomas, J.D. Walker, R. Mukherjee, L. Hebbar Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function Circ Res 82 1998 482 495
4. S.E. Campbell, A.A. Diaz-Arias, K.T. Weber Myocardial rupture postinfarction K.T. Weber Wound Healing in Cardiovascular Disease 1995 Futura Publishing Armonk, NY 49 60
5. K.T. Weber Cardiac interstitium in health and disease: the fibrillar collagen network J Am Coll Cardiol 13 1989 1637 1652
6. P.J. Armstrong, J.M. Johanning, W.C. Calton, J.R. Delatore, D.P. Franklin, D.C. Han, D.J. Carey, J.R. Elmore Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease J Vasc Surg 35 2002 346 355
7. P. Mignatti, D.B. Rifkin Plasminogen activators and matrix metalloproteinases in angiogenesis Enzyme Protein 49 1996 117 137
8. B. Maisch, A.D. Ristic, S. Pankuweit, A. Neubauer, R. Moll Neoplastic pericardial effusion Efficacy and safety of intrapericardial treatment with cisplatin Eur Heart J 23 2002 1625 1631
9. O. Eickelberg, C.O. Sommerfeld, C. Wyser, M. Tamm, F. Reichenberger, P.G. Bardin, M. Soler, M. Roth, A.P. Perruchoud MMP and TIMP expression pattern in pleural effusions of different origins Am J Respir Crit Care Med 156 1997 1987 1992
10. V.M. Macaulay, K.J. O'Byrne, M.P. Saunders, J.P. Braybrooke, L. Long, F. Gleeson, C.S. Mason, A.L. Harris, P. Brown, D.C. Talbot Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions Clin Cancer Res 5 1999 513 520
11. B. Maisch, A. Ristic, S. Pankuweit Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone The way to avoid side effects of systemic corticosteroid therapy Eur Heart J 23 2002 1503 1508
12. B. Maisch Pericardial diseases, with a focus on etiology, pathogenesis, pathophysiology, new diagnostic imaging methods, and treatment Curr Opin Cardiol 9 1994 379 388
13. B. Maisch, A.D. Ristic The classification of pericardial disease in the age of modern medicine Curr Cardiol Rep 4 2002 13 21
14. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, H. Feigenbaum, H. Gutgesell, N. Reichek, D. Sahn, I. Schnittger Recommendations for quantitation of the left ventricle by two-dimensional echocardiography American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
15. M.S. Horowitz, C.S. Schultz, E.B. Stinson, D.C. Harrison, R.L. Popp Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion Circulation 50 1974 239 247
16. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
17. S.C. Tyagi, L. Matsubara, K.T. Weber Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus Clin Biochem 26 1993 191 198
18. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
19. H. Towbin, T. Staehelin, J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci USA 76 1979 4350 4354
20. M. Fujita, M. Ikemoto, M. Kishishita, H. Otani, R. Nohara, T. Tanaka, S. Tamaki, A. Yamazato, S. Sasayama Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina Circulation 94 1996 610 613
21. F. Horkay, I. Szokodi, L. Selmeci, B. Merkely, V. Kekesi, T. Vecsey, O. Vuolteenaho, H. Ruskoaho, A. Juhasz-Nagy, M. Toth Presence of immunoreactive endothelin-1 and atrial natriuretic peptide in human pericardial fluid Life Sci 62 1998 267 274
22. S. Miyamoto, N. Nagaya, M. Ikemoto, K. Tambara, Y. Kihara, Y. Onozawa, K. Hasegawa, A. Yamazato, M. Fujita Elevation of matrix metalloproteinase-2 level in pericardial fluid is closely associated with left ventricular remodeling Am J Cardiol 89 2002 102 105
23. E.M. Wilson, H.R. Gunasinghe, M.L. Coker, P. Sprunger, D. Lee-Jackson, B. Bozkurt, A. Deswal, D.L. Mann, F.G. Spinale Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure J Card Fail 8 2002 390 398
24. A. Diwan, T. Tran, A. Misra, D.L. Mann Inflammatory mediators and the failing heart: a translational approach Curr Mol Med 3 2003 161 182
25. P. Vihinen, V.M. Kahari Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets Int J Cancer 99 2002 157 166
26. M.L. Coker, M.A. Doscher, C.V. Thomas, Z.S. Galis, F.G. Spinale Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations Am J Physiol 277 1999 H777 H787
27. R. Visse, H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 2003 827 839
28. A. Luttun, M. Dewerchin, D. Collen, P. Carmeliet The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies Curr Atheroscler Rep 2 2000 407 416
29. N. Di Girolamo, N. Tedla, A. Lloyd, D. Wakefield Expression of matrix metalloproteinases by human plasma cells and B lymphocytes Eur J Immunol 28 1998 1773 1784
30. G. Pasterkamp, A.H. Schoneveld, D.J. Hijnen, D.P. de Kleijn, H. Teepen, A.C. van der Wal, C. Borst Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2, and 9 in the human coronary artery Atherosclerosis 150 2000 245 253